Contraceptive UsageTECCNCT06682065
Telemedicine Contraceptive Counselling (TECC) Versus Standard Care
A study testing Telemedicine for contraceptive counseling (TECC) in people with Contraceptive Usage and Telemedicine, run by Karolinska Institutet at 2 sites in South Africa.
Trial summary
Overall purpose of the PILOT and RCT: This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Contraceptive Usage, Telemedicine
- What is being tested?
- Telemedicine for contraceptive counseling (TECC)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 510 participants
- Where
- 2 sitesSouth Africa
- Study dates
- 5 May 2024to 15 Feb 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
- Seeking either surgical or medical abortion
- ≥ 18 years of age
- Able to communicate and understand spoken and written English
- With private access to a smart phone
- Willing to participate in the study procedures
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
South Africa2 sites, 2 recruiting
- Recruiting
Michael Mapongwana
Cape Town
Khanyisa Jacobs, RNM
- Recruiting
Mitchell´s Plain CHC
Cape Town
Margit Endler, 0789106286, margit.endler@ki.se
About this study
Official title: Telemedicine Contraceptive Counselling (TECC) Versus Standard Care - a Pilot and Randomized Controlled Trial of Periabortion Contraceptive Counseling
Overall purpose of the PILOT and RCT:
This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:
Read the detailed description
Overall purpose of the PILOT and RCT:
This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:
- To design and test a user-friendly online service for contraceptive counseling informed by systematic research into the preference and experience of women in our study setting.
- To compare uptake of long-acting reversible contraception (LARC) after TECC and in-person contraceptive counseling.
- To compare rates of choice, uptake, and continuation of LARC or any contraceptive, satisfaction, preference for counseling, recurrent unintended pregnancy, and recurrent abortion after TECC and in-person contraceptive counseling.
PILOT STUDY Objective: To assess the acceptability of a new online e-health service for contraceptive counselling i.e., telemedicine contraceptive counseling (TECC)
Design: A mixed methods pilot study developing and testing a new TECC service preceding a randomized controlled trial Setting and duration: The study will take place at Mitchell's Plain's community health center (CHC) in Western Cape, between February November 2023 and December 2023.
Study population: 30 women seeking abortion either medical or surgical, ≥ 18 years of age, able to communicate and understand spoken and written English, with private access to a smartphone, and willing to participate in the study
Recruitment and consent: Recruitment, informed consent, baseline interview and randomization will take place at the clinics by one of two experienced field workers, fluent in English and isiXhosa/Afrikaans.
Intervention: Participants will test the TECC service while waiting at the clinic to see the nurse for their abortion consultation. A follow-up survey will be sent out and completed by phone if necessary at 2 weeks after enrolment in the study. Out of these 30 women, approximately 10 (or until data saturation is achieved) will participate in semi-structured in-depth interviews regarding their experience of using the TECC service.
Primary outcome collected at 2 weeks Main outcome variable will be a compound variable reflecting the proportion of women who choose a method after completing the TECC intervention and report 1) being satisfied or very satisfied with the service (affective attitude), 2) understanding the content and purpose of the intervention (coherence), 3) feeling confident in their ability to use the service (self-efficacy), 4) experiencing the service as easy to use (burden), 5) assessing service as likely to be of use in the community (effectiveness)
Secondary outcomes collected at 2 weeks
- Contraceptive method chosen by type (%)
- Choice of LARC (%), defined as choice of an IUD or a subdermal implant for contraception
- Change of method with respect to previous use (%)
Qualitative component Data collection - qualitative component Data will be collected through semi structured in depth interviews (IDIs), held in person or by phone after the second quantitative data collection point. The sample size is estimated to be until data saturation or up to 10 interviews. The interview guide for the IDIs will be developed to capture measures of the acceptability of the TECC service according to Sekhon et al.'s framework, i.e. how participants feel about the intervention (affective attitude), how much effort is required to participate in the intervention (burden), how well the intervention fits with the participants value system (ethicality), how well the intervention is understood (coherence), what benefits must be given up to utilize the intervention (opportunity costs), how likely the intervention is to work (perceived effectiveness), and the participants confidence in being able to use the intervention (self-efficacy). Emphasis will be on enhancing the quantitative findings and gaining a more comprehensive understanding of the acceptability of the TECC intervention. Especially aspects of the framework that are more difficult to explore quantitatively, such as ethicality and opportunity costs will be explored. Questions will be open ended, allowing new themes to emerge from the data, and the interview guide may be adapted to accommodate and explore themes emerging in the interviews.
RANDOMIZED CONTROLLED TRIAL
Objective:
Setting:
Population: 510 women seeking abortion either medical or surgical, < 13+0 weeks gestation, ≥18 years of age, able to communicate and understand spoken and written English, with private access to a smart phone, and willing to participate in the study.
Recruitment and consent: Recruitment, informed consent, baseline interview and randomization will take place at the clinics by one of two experienced field workers, fluent in English and isiXhosa/Afrikaans.
RCT: Participants will be randomly assigned to either standard care or TECC.
- Standard care: Contraceptive counselling with clinic nurse.
- TECC: While waiting for their abortion consultation with the clinic nurse, participants will use their phones to complete a contraceptive counseling session through the TECC service.
Outcome measures: The investigators will compare effectiveness and acceptability of the service between the telemedicine and the standard care arm. Follow-up will through links ot online surveys in RedCap at 12 weeks, 6 months and 12 months after the initial consultation.
Primary outcome at 12 weeks Uptake of LARC, defined as uptake of an IUD or a subdermal implant for contraception, within 12 weeks Secondary outcomes at 12 weeks
- choice of LARC
- uptake of any contraception
- choice or uptake of new method with regards to previous use
- satisfaction with TECC service (using a a multi-question validated scale)
- Rated use of service for decision making (using a multi-question validated scale)
- Degree of agency in decision making (using a a multi-question validated scale)
- preference for counselling Secondary outcomes at 6 months
- continued use of LARC 2. continued use of any contraception 3. recurrent unintended pregnancy 4. recurrent abortion Secondary outcomes at 12 months
- continued use of LARC
- continued use of any contraception
- recurrent unintended pregnancy
- recurrent abortion
- Change of method at any timepoint up to 12 months
- Reason for change of method
- Conditions
- Contraceptive Usage, Telemedicine
- Being tested
- Telemedicine for contraceptive counseling (TECC), Standard Care
- Medical subject headings
- Contraception Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telemedicine for contraceptive counseling (TECC)Other
WhatsApp algorithmic chatbot that screens preferences and medical eligibility to recommend two methods, informs about all methods, allows choice out of all methods, produce summary to substitute for clinical record
Standard CareOther
In-personcontraceptive counseling with a nurese according to clinical standard of care
| Study group | Role | What they receive |
|---|---|---|
| Telemedicine | Experimental | WhatsApp algorithmic chatbot see further description Receives: Other: Telemedicine for contraceptive counseling (TECC) |
| Standard Care | Active comparator | Standard of care contraceptive counseling with clinic nurse Receives: Other: Standard Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Use of LARC (IUD or progestin implant) at 12 week follow-up
Proportion of participants in each arm with using LARC (IUD or progestin implant) at 12 week follow-up
Measured: 12 weeks
Secondary outcomes (12)
Choice of LARC on day of consultation
Proportion of participants in each arm chosing LARC on day of first visit (recruitment)
Measured: Baseline
Use of LARC at 6 months
Proportion of participants in each arm using LARC at 6 months follow-up
Measured: 6 months
Use of LARC at 12 months
Proportion of participants in each arm using LARC at 12 months follow-up
Measured: 12 months
Unplanned pregnancy within 6 months
Proportion of participants in each arm with unplanned pregnancy recorded at 6 month follow-up and having occurred since previous abortion
Measured: 6 months
Unplanned pregnancy within 12 months
Proportion of participants in each arm with unplanned pregnancy recorded at 12 month follow-up and having occurred since previous abortion.
Measured: 12 months
Recurrent abortion within 6 months
Proportion of participants in each arm with recurrent abortion recorded at 6 month follow-up and having occurred since previous abortion
Measured: 6 months
Recurrent abortion within 12 months
Proportion of participants in each arm with recurrent abortion recorded at 12 month follow-up and having occurred since previous abortion
Measured: 12 months
Preference for counseling model
Proportion of participants in each arm using expressing preference for telemedicine counseling model
Measured: Baseline
Satisfaction with contraceptive counseling
validated scale (0-6)
Measured: Baseline
Decision-competence after contraceptive counseling
validated scale (0-100)
Measured: Baseline
Agency in contraceptive decision making
modified validated scale
Measured: Baseline
Change of contraceptive method
Change of contraceptive method
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Nov 2024
- Study start5 May 2024
- Primary completion15 Feb 2025 (estimated)
- Study completion15 Feb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Contraceptive UsageStudies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- 1:1
- Masking
- None (open label)
- Enrolment
- 510 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Collaborators
- University of Cape Town
- Responsible party
- Principal investigator, Margit Endler, Karolinska Institutet
- Investigators
- Margit Endler, PhD, Principal investigator, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06682065
- Sponsor's protocol ID
- TECC
- Acronym
- TECC
- Status last verified
- Nov 2024
- First submitted
- 8 Apr 2024
- Last updated
- 12 Nov 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Pseudonymized data will be made available to other researchers upon reasonable request
Study at a glance
From the registry record, last updated by the sponsor on 12 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Telemedicine Contraceptive Counselling (TECC) Versus Standard Care - a Pilot and Randomized Controlled Trial of Periabortion Contraceptive Counseling
- ClinicalTrials.gov ID
- NCT06682065
- Acronym / sponsor ID
- TECC / TECC
- Conditions
- Contraceptive Usage, Telemedicine
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 510 participants (estimated)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Collaborators
- University of Cape Town
- Study start
- 5 May 2024 (actual)
- Primary completion
- 15 Feb 2025 (estimated)
- Study completion
- 15 Feb 2026 (estimated)
- First posted
- 12 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Overall purpose of the PILOT and RCT:
This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:
Detailed description
Overall purpose of the PILOT and RCT:
This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:
- To design and test a user-friendly online service for contraceptive counseling informed by systematic research into the preference and experience of women in our study setting.
- To compare uptake of long-acting reversible contraception (LARC) after TECC and in-person contraceptive counseling.
- To compare rates of choice, uptake, and continuation of LARC or any contraceptive, satisfaction, preference for counseling, recurrent unintended pregnancy, and recurrent abortion after TECC and in-person contraceptive counseling.
PILOT STUDY Objective: To assess the acceptability of a new online e-health service for contraceptive counselling i.e., telemedicine contraceptive counseling (TECC)
Design: A mixed methods pilot study developing and testing a new TECC service preceding a randomized controlled trial Setting and duration: The study will take place at Mitchell's Plain's community health center (CHC) in Western Cape, between February November 2023 and December 2023.
Study population: 30 women seeking abortion either medical or surgical, ≥ 18 years of age, able to communicate and understand spoken and written English, with private access to a smartphone, and willing to participate in the study
Recruitment and consent: Recruitment, informed consent, baseline interview and randomization will take place at the clinics by one of two experienced field workers, fluent in English and isiXhosa/Afrikaans.
Intervention: Participants will test the TECC service while waiting at the clinic to see the nurse for their abortion consultation. A follow-up survey will be sent out and completed by phone if necessary at 2 weeks after enrolment in the study. Out of these 30 women, approximately 10 (or until data saturation is achieved) will participate in semi-structured in-depth interviews regarding their experience of using the TECC service.
Primary outcome collected at 2 weeks Main outcome variable will be a compound variable reflecting the proportion of women who choose a method after completing the TECC intervention and report 1) being satisfied or very satisfied with the service (affective attitude), 2) understanding the content and purpose of the intervention (coherence), 3) feeling confident in their ability to use the service (self-efficacy), 4) experiencing the service as easy to use (burden), 5) assessing service as likely to be of use in the community (effectiveness)
Secondary outcomes collected at 2 weeks
- Contraceptive method chosen by type (%)
- Choice of LARC (%), defined as choice of an IUD or a subdermal implant for contraception
- Change of method with respect to previous use (%)
Qualitative component Data collection - qualitative component Data will be collected through semi structured in depth interviews (IDIs), held in person or by phone after the second quantitative data collection point. The sample size is estimated to be until data saturation or up to 10 interviews. The interview guide for the IDIs will be developed to capture measures of the acceptability of the TECC service according to Sekhon et al.'s framework, i.e. how participants feel about the intervention (affective attitude), how much effort is required to participate in the intervention (burden), how well the intervention fits with the participants value system (ethicality), how well the intervention is understood (coherence), what benefits must be given up to utilize the intervention (opportunity costs), how likely the intervention is to work (perceived effectiveness), and the participants confidence in being able to use the intervention (self-efficacy). Emphasis will be on enhancing the quantitative findings and gaining a more comprehensive understanding of the acceptability of the TECC intervention. Especially aspects of the framework that are more difficult to explore quantitatively, such as ethicality and opportunity costs will be explored. Questions will be open ended, allowing new themes to emerge from the data, and the interview guide may be adapted to accommodate and explore themes emerging in the interviews.
RANDOMIZED CONTROLLED TRIAL
Objective:
Setting:
Population: 510 women seeking abortion either medical or surgical, < 13+0 weeks gestation, ≥18 years of age, able to communicate and understand spoken and written English, with private access to a smart phone, and willing to participate in the study.
Recruitment and consent: Recruitment, informed consent, baseline interview and randomization will take place at the clinics by one of two experienced field workers, fluent in English and isiXhosa/Afrikaans.
RCT: Participants will be randomly assigned to either standard care or TECC.
- Standard care: Contraceptive counselling with clinic nurse.
- TECC: While waiting for their abortion consultation with the clinic nurse, participants will use their phones to complete a contraceptive counseling session through the TECC service.
Outcome measures: The investigators will compare effectiveness and acceptability of the service between the telemedicine and the standard care arm. Follow-up will through links ot online surveys in RedCap at 12 weeks, 6 months and 12 months after the initial consultation.
Primary outcome at 12 weeks Uptake of LARC, defined as uptake of an IUD or a subdermal implant for contraception, within 12 weeks Secondary outcomes at 12 weeks
- choice of LARC
- uptake of any contraception
- choice or uptake of new method with regards to previous use
- satisfaction with TECC service (using a a multi-question validated scale)
- Rated use of service for decision making (using a multi-question validated scale)
- Degree of agency in decision making (using a a multi-question validated scale)
- preference for counselling Secondary outcomes at 6 months
- continued use of LARC 2. continued use of any contraception 3. recurrent unintended pregnancy 4. recurrent abortion Secondary outcomes at 12 months
- continued use of LARC
- continued use of any contraception
- recurrent unintended pregnancy
- recurrent abortion
- Change of method at any timepoint up to 12 months
- Reason for change of method
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- 1:1
| Arm | Type | Receives |
|---|---|---|
| Telemedicine | Experimental | Other: Telemedicine for contraceptive counseling (TECC)WhatsApp algorithmic chatbot see further description |
| Standard Care | Active comparator | Other: Standard CareStandard of care contraceptive counseling with clinic nurse |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Telemedicine for contraceptive counseling (TECC)WhatsApp algorithmic chatbot that screens preferences and medical eligibility to recommend two methods, informs about all methods, allows choice out of all methods, produce summary to substitute for clinical record | Other | Telemedicine |
| Standard CareIn-personcontraceptive counseling with a nurese according to clinical standard of care | Other | Standard Care |
Primary outcome
Use of LARC (IUD or progestin implant) at 12 week follow-up
Time frame: 12 weeks
Proportion of participants in each arm with using LARC (IUD or progestin implant) at 12 week follow-up
12 secondary outcomes
Choice of LARC on day of consultation
Time frame: Baseline
Use of LARC at 6 months
Time frame: 6 months
Use of LARC at 12 months
Time frame: 12 months
Unplanned pregnancy within 6 months
Time frame: 6 months
Unplanned pregnancy within 12 months
Time frame: 12 months
Recurrent abortion within 6 months
Time frame: 6 months
Recurrent abortion within 12 months
Time frame: 12 months
Preference for counseling model
Time frame: Baseline
Satisfaction with contraceptive counseling
Time frame: Baseline
Decision-competence after contraceptive counseling
Time frame: Baseline
Agency in contraceptive decision making
Time frame: Baseline
Change of contraceptive method
Time frame: 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Nov 2024.
- Individual participant dataSharing planned: No. Pseudonymized data will be made available to other researchers upon reasonable request
Related trials for Contraceptive Usage
Enrolling by invitation
Flo Digital Contraceptive Study
Contraception Use
Not yet recruitingObservational study
FLOW: Influence of the Menstrual Cycle on Alcohol Use in Women
Alcohol Use, Alcohol Consumption
Not yet recruiting
Impact of Gender-Transformative Interventions on Contraceptive Use and Reproductive Autonomy in Somalia
Contraceptive Behavior, Social Norms
Recruiting
Impact of Self-Care Family Planning Services on Health and Development in South Sudan (Family Planning Impact Lab)
Contraceptive Behavior, Self Administration
Enrolling by invitation
A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions
Contraceptive Usage, Contraceptive Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Margit Endler, PhD principal investigator
Karolinska Institutet
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Telemedicine for contraceptive counseling (TECC) in people with Contraceptive Usage and Telemedicine, run by Karolinska Institutet at 2 sites in South Africa.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Margit Endler (0789106286, margit.endler@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Use of LARC (IUD or progestin implant) at 12 week follow-up (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2024.